Antibody-Drug Conjugates Targeting the Urokinase Receptor (uPAR) as a Possible Treatment of Aggressive Breast Cancer.
Harel ET, Drake PM, Barfield RM, Lui I, Farr-Jones S, Van't Veer L, Gartner ZJ, Green EM, Lourenço AL, Cheng Y, Hann BC, Rabuka D, Craik CS.
Harel ET, et al. Among authors: drake pm.
Antibodies (Basel). 2019 Nov 5;8(4):54. doi: 10.3390/antib8040054.
Antibodies (Basel). 2019.
PMID: 31694242
Free PMC article.